CLIMB BIO, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CLIMB BIO, INC. (CLYM) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 8.61 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- CLIMB BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 8.61M shares, a 36.87% increase year-over-year.
- CLIMB BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 8.71M shares, a 34.61% increase year-over-year.
- CLIMB BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 6.29M shares, a 54.63% increase year-over-year.
- CLIMB BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 6.47M shares, a 45.41% increase year-over-year.
- CLIMB BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 6.66M shares, a 64.57% increase from fiscal 2024.
- CLIMB BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 4.05M shares, a 14.56% decline from fiscal 2023.
- CLIMB BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 4.74M shares, a 23.18% decline from fiscal 2022.
- CLIMB BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 6.17M shares, a 89.45% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 8.61M shares 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 8.71M shares 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 6.66M shares 10-K · filed 2026-03-05 | |||
| 2025-09-30 | 5.28M shares 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 6.29M shares 10-Q · filed 2026-08-06 | 6.29M shares 10-Q · filed 2025-08-12 | ||
| 2025-03-31 | 6.47M shares 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 4.05M shares 10-K · filed 2026-03-05 | |||
| 2024-09-30 | 4.08M shares 10-Q · filed 2024-11-12 | 4.08M shares 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | 4.07M shares 10-Q · filed 2024-08-14 | 4.07M shares 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | 4.45M shares 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | 4.74M shares 10-K · filed 2025-03-25 | |||
| 2023-09-30 | 5.08M shares 10-Q · filed 2024-11-12 | 5.08M shares 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | 5.57M shares 10-Q · filed 2024-08-14 | 5.57M shares 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | 5.74M shares 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | 6.17M shares 10-K · filed 2024-03-28 | |||
| 2022-09-30 | 4.75M shares 10-Q · filed 2022-11-14 | 4.75M shares 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | 4.82M shares 10-Q · filed 2022-08-15 | 4.82M shares 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | 4.60M shares 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | 3.25M shares 10-K · filed 2023-03-06 | |||
| 2021-09-30 | 3.09M shares 10-Q · filed 2022-11-14 | 3.09M shares 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | 18.34M shares 10-Q · filed 2022-08-15 | 18.34M shares 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | 13.51M shares 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | 11.36M shares 10-K · filed 2022-03-07 | |||
| 2020-09-30 | 4.48M shares 10-Q · filed 2021-11-08 | 4.48M shares 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | 4.49M shares 10-Q · filed 2021-09-13 | 4.49M shares 10-Q · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |